Oramed Pharmaceuticals
ORMP
ORMP
30 hedge funds and large institutions have $3.21M invested in Oramed Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
7% less call options, than puts
Call options by funds: $984K | Put options by funds: $1.06M
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
30
Holding in Top 10
–
Calls
$984K
Puts
$1.06M
Top Buyers
| 1 | +$586K | |
| 2 | +$81.4K | |
| 3 | +$77.1K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$31K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$15K |
Top Sellers
| 1 | -$593K | |
| 2 | -$196K | |
| 3 | -$82.1K | |
| 4 |
BlackRock
New York
|
-$71.1K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$51K |